TNG-260 | m-entrepreneurship.com

Product Name :
TNG-260

Search keywords :
CoREST

drugId :
null

Target Vo:
Histone deacetylase 1

Target Vo Short Name :
HDAC1

Moa_Name:
Histone deacetylase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Tango Therapeutics Inc

Active Company_Name :
Tango Therapeutics Inc

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AKT Rabbit mAb supplier
PI 3 Kinase p85 alpha Rabbit mAb Purity & Documentation
Retinoic Acid Receptor alpha Antibody: Retinoic Acid Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Retinoic Acid Receptor alpha. It can be used for WB,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts